Ling Zhang

Boehringer Ingelheim Pharmaceuticals, Inc.

Poster(s):

• (142) Diabetes and IBD: Utilization of High Dimensional Propensity Score Methods for Screening and Balancing Risk Factors Between Type 2 Diabetes and Non-Diabetes Population in Risk of IBD Assessment
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (140) The Utility of Data Tokenization for Real World Data (RWD) Access in Clinical Trials
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST